Two Sigma Advisers
IMRX icon

Two Sigma Advisers’s Immuneering IMRX Stock Holding History

Two Sigma Advisers’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,800
Closed -$209K – 1034
2025
Q4 		$209K Buy
+31,800
New +$204K ﹤0.01% 2109
2024
Q3 		– Sell
-248,700
Closed -$318K – 2388
2024
Q2 		$318K Buy
+248,700
New +$409K ﹤0.01% 2050
2022
Q3 		– Sell
-11,100
Closed -$60K – 2641
2022
Q2 		$60K Sell
11,100
-2,200
-17% -$11.7K ﹤0.01% 2459
2022
Q1 		$86K Buy
+13,300
New +$128K ﹤0.01% 2526

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers's IMRX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Immuneering (IMRX) in Q1 2026, closing a stake of 31,800 shares — an estimated $209K sold.

Two Sigma Advisers first reported a position in IMRX in Q1 2022 and held it in 4 quarters. The position peaked at $318K in Q2 2024. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Immuneering position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 31,800 Immuneering shares in Q1 2026, an estimated $209K.
  • Two Sigma Advisers first reported a position in Immuneering in Q1 2022 and held it in 4 quarters.
  • Two Sigma Advisers's Immuneering position peaked at $318K in Q2 2024.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.